In Vitro and In Vivo Profiles of ACH-702, an Isothiazoloquinolone, against Bacterial Pathogens

In Vitro Activity of a New Isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and Other Mycobacteria

(2010) C. A. Molina-Torres et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activity of ACH-702, a New Isothiazoloquinolone, against Nocardia brasiliensis Compared with Econazole and the Carbapenems Imipenem and Meropenem Alone or in Combination with Clavulanic Acid

(2010) L. Vera-Cabrera et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Antituberculosis Activities of ACH-702, a Novel Isothiazoloquinolone, against Quinolone-Susceptible and Quinolone-Resistant Isolates

(2010) M. J. Pucci et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

VanA-Type Vancomycin-Resistant Staphylococcus aureus

(2009) B. Perichon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The antimicrobial resistance profile of Streptococcus pneumoniae

(2009) R.R. Reinert   CLINICAL MICROBIOLOGY AND INFECTION

Antibiotic-Resistant Bugs in the 21st Century — A Clinical Super-Challenge

(2009) Cesar A. Arias et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Current challenges in treating MRSA: what are the options?

(2008) Natasha VDV Ratnaraja et al.   Expert Review of Anti-Infective Therapy